IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes.
Joseph, Julie
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Jan 2012 - 216-21 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1550-6606
10.4049/jimmunol.1101215 doi
Animals
Cyclophosphamide--adverse effects
Diabetes Mellitus, Type 1--chemically induced
Immunosuppressive Agents--adverse effects
Interleukin-17--genetics
Lentivirus
Mice
Mice, Inbred NOD
RNA Interference
Th1 Cells--immunology
Th17 Cells--immunology
Transduction, Genetic--methods
IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Jan 2012 - 216-21 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1550-6606
10.4049/jimmunol.1101215 doi
Animals
Cyclophosphamide--adverse effects
Diabetes Mellitus, Type 1--chemically induced
Immunosuppressive Agents--adverse effects
Interleukin-17--genetics
Lentivirus
Mice
Mice, Inbred NOD
RNA Interference
Th1 Cells--immunology
Th17 Cells--immunology
Transduction, Genetic--methods